|
Name |
Isoeugenitol
|
Molecular Formula | C11H10O4 | |
IUPAC Name* |
5,7-dihydroxy-2,8-dimethylchromen-4-one
|
|
SMILES |
CC1=CC(=O)C2=C(C=C(C(=C2O1)C)O)O
|
|
InChI |
InChI=1S/C11H10O4/c1-5-3-8(13)10-9(14)4-7(12)6(2)11(10)15-5/h3-4,12,14H,1-2H3
|
|
InChIKey |
XSSGQRFNGHRFBC-UHFFFAOYSA-N
|
|
Synonyms |
Isoeugenitol; 5,7-dihydroxy-2,8-dimethylchromone; 479-06-1; KBio1_001073; Spectrum_000601; SpecPlus_000033; Spectrum2_000569; Spectrum3_000687; Spectrum4_001501; Spectrum5_000261; BSPBio_002413; KBioGR_002161; KBioSS_001081; SPECTRUM200449; DivK1c_006129; SPBio_000358; CHEMBL1371435; SCHEMBL18517012; CHEBI:92103; KBio2_001081; KBio2_003649; KBio2_006217; KBio3_001633; DTXSID601318026; CCG-38735; SDCCGMLS-0066885.P001; NCGC00095479-01; NCGC00095479-02; NCGC00178664-01; 5,7-dihydroxy-2,8-dimethyl-4H-chromen-4-one; 5,7-dihydroxy-2,8-dimethyl-1-benzopyran-4-one; BRD-K05737787-001-02-2; Q27163895
|
|
CAS | 479-06-1 | |
PubChem CID | 5318562 | |
ChEMBL ID | CHEMBL1371435 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 206.19 | ALogp: | 2.1 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.694 |
Caco-2 Permeability: | -4.793 | MDCK Permeability: | 0.00001040 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.892 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.017 |
30% Bioavailability (F30%): | 0.563 |
Blood-Brain-Barrier Penetration (BBB): | 0.02 | Plasma Protein Binding (PPB): | 90.04% |
Volume Distribution (VD): | 0.66 | Fu: | 12.12% |
CYP1A2-inhibitor: | 0.978 | CYP1A2-substrate: | 0.952 |
CYP2C19-inhibitor: | 0.155 | CYP2C19-substrate: | 0.141 |
CYP2C9-inhibitor: | 0.372 | CYP2C9-substrate: | 0.86 |
CYP2D6-inhibitor: | 0.513 | CYP2D6-substrate: | 0.515 |
CYP3A4-inhibitor: | 0.179 | CYP3A4-substrate: | 0.215 |
Clearance (CL): | 8.444 | Half-life (T1/2): | 0.795 |
hERG Blockers: | 0.003 | Human Hepatotoxicity (H-HT): | 0.087 |
Drug-inuced Liver Injury (DILI): | 0.941 | AMES Toxicity: | 0.585 |
Rat Oral Acute Toxicity: | 0.188 | Maximum Recommended Daily Dose: | 0.772 |
Skin Sensitization: | 0.817 | Carcinogencity: | 0.151 |
Eye Corrosion: | 0.169 | Eye Irritation: | 0.94 |
Respiratory Toxicity: | 0.369 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001518 | 0.667 | D0FA2O | 0.381 | ||||
ENC001940 | 0.667 | D0G4KG | 0.368 | ||||
ENC004786 | 0.608 | D04AIT | 0.342 | ||||
ENC006031 | 0.566 | D0K8KX | 0.299 | ||||
ENC001755 | 0.538 | D06GCK | 0.298 | ||||
ENC004675 | 0.537 | D07MGA | 0.263 | ||||
ENC005717 | 0.528 | D0O6KE | 0.261 | ||||
ENC005716 | 0.528 | D0N0OU | 0.245 | ||||
ENC001495 | 0.509 | D0Y7PG | 0.237 | ||||
ENC001617 | 0.500 | D0H2ZW | 0.232 |